IRTC - Irhythm Holdings, Inc.

Insider Sale by Smith Mervin (EVP Strategic Business Ops)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Smith Mervin, serving as EVP Strategic Business Ops at Irhythm Holdings, Inc. (IRTC), sold 1,352 shares at $128.44 per share, for a total transaction value of $173,652.00. Following this transaction, Smith Mervin now holds 25,612 shares of IRTC.

This sale represents a 5.00% decrease in Smith Mervin's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 3, 2026, 1 day after the trade was made.

Irhythm Holdings, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Smith Mervin

EVP Strategic Business Ops

Mervin Smith is the Executive Vice President of Business Operations at iRhythm Technologies, Inc. (NASDAQ: IRTC), a position he has held since July 2023[[2]](https://investors.irhythmtech.com/governance/board-of-directors/person-details/default.aspx?ItemId=8e98831c-a4b5-42d1-a8a6-48925d1ca8df). In this role, he oversees the company's Global Business Services center, Clinical Operations, Manufacturing, and Business Operations[[2]](https://investors.irhythmtech.com/governance/board-of-directors/person-details/default.aspx?ItemId=8e98831c-a4b5-42d1-a8a6-48925d1ca8df). Smith brings extensive experience from the medical technology sector, having spent 20 years at Zimmer Biomet, a global medical device company, where he held executive leadership positions including Vice President and General Manager for Surgical, Restorative Therapies, and Office-Based Technologies[[2]](https://investors.irhythmtech.com/governance/board-of-directors/person-details/default.aspx?ItemId=8e98831c-a4b5-42d1-a8a6-48925d1ca8df). In these roles, he built and led teams focused on operational excellence while managing global sales, commercial channels, and full P&L responsibilities across multiple business units[[2]](https://investors.irhythmtech.com/governance/board-of-directors/person-details/default.aspx?ItemId=8e98831c-a4b5-42d1-a8a6-48925d1ca8df). Smith holds an MBA from Ball State University and a Bachelor of Science in Accounting from the University of Pittsburgh[[2]](https://investors.irhythmtech.com/governance/board-of-directors/person-details/default.aspx?ItemId=8e98831c-a4b5-42d1-a8a6-48925d1ca8df). He has also completed Stanford Biodesign's executive education program, "Managing Innovation from the Inside Out," which focuses on driving innovation within organizations[[2]](https://investors.irhythmtech.com/governance/board-of-directors/person-details/default.aspx?ItemId=8e98831c-a4b5-42d1-a8a6-48925d1ca8df). As of February 2026, Smith directly owns 20,275 shares of iRhythm common stock following recent equity transactions, including the vesting of performance-based restricted stock units[[3]](https://www.stocktitan.net/sec-filings/IRTC/form-4-i-rhythm-holdings-inc-insider-trading-activity-6e0d2e3f4b1c.html).

View full insider profile →

Trade Price

$128.44

Quantity

1,352

Total Value

$173,652.00

Shares Owned

25,612

Trade Date

Monday, March 2, 2026

3 days ago

SEC Filing Date

Tuesday, March 3, 2026

Filed 1 day after trade

HEALTHCAREMEDICAL DEVICES

About Irhythm Holdings, Inc.

Company Overview

No company information available
View news mentioning IRTC

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4470952

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime